Cargando…
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
Vaccination against coronavirus disease 2019 (COVID-19) has contributed greatly to providing protection against severe disease, thereby reducing hospital admissions and deaths. Several studies have reported reduction in vaccine effectiveness over time against the Omicron sub-lineages. However, the w...
Autores principales: | Tan, Ngoc H., Sablerolles, Roos S. G., Rietdijk, Wim J. R., Goorhuis, Abraham, Postma, Douwe F., Visser, Leo G., Bogers, Susanne, Geers, Daryl, Zaeck, Luca M., Koopmans, Marion P. G., Dalm, Virgil A. S. H., Kootstra, Neeltje A., Huckriede, Anke L. W., van Baarle, Debbie, Lafeber, Melvin, GeurtsvanKessel, Corine H., de Vries, Rory D., van der Kuy, Paul-Hugo Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744953/ https://www.ncbi.nlm.nih.gov/pubmed/36524126 http://dx.doi.org/10.3389/fimmu.2022.1067749 |
Ejemplares similares
-
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
por: Sablerolles, Roos S. G., et al.
Publicado: (2021) -
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers
por: Sablerolles, Roos S G, et al.
Publicado: (2022) -
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022) -
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
por: Tan, Ngoc H, et al.
Publicado: (2023) -
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
por: Geers, Daryl, et al.
Publicado: (2022)